Hims & Hers Health Inc. ($HIMS) Stock Forecast: Down 7.6% Today

What is Hims & Hers Health Inc.?

Hims & Hers Health (HIMS) is a company focused on telehealth and wellness products, catering to a wide range of health needs.

Why is Hims & Hers Health Inc. going down?

HIMS stock is down 7.6% on Mar 28, 2025 17:39

• The stock of HIMS experienced a strong bearish movement recently.
• Smart money investors have taken a notably bearish stance on HIMS options, as a significant percentage have opened trades with bearish sentiments.
• The stock has been down 7.1% since the last earnings report, prompting concerns about its ability to rebound.
• The overall options activity for HIMS is leaning towards a bearish outlook, potentially contributing to the downward trend in the stock price.

HIMS Price Chart

HIMS Technical Analysis

HIMS News

Smart Money Is Betting Big In HIMS Options - Hims & Hers Health ( NYSE:HIMS )

Whales with a lot of money to spend have taken a noticeably bearish stance on Hims & Hers Health. Looking at options history for Hims & Hers Health HIMS we detected 24 trades. If we consider the specifics of each trade, it is accurate to state that 20% of the investors opened trades with bullish ...

https://www.benzinga.com/insights/options/25/03/44541292/smart-money-is-betting-big-in-hims-options

Hims & Hers Health ( HIMS ) Down 7.1% Since Last Earnings Report: Can It Rebound?

Hims & Hers Health (HIMS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

https://www.zacks.com/stock/news/2435634/hims-hers-health-hims-down-71-since-last-earnings-report-can-it-rebound

Decoding Hims & Hers Health's Options Activity: What's the Big Picture? - Hims & Hers Health ( NYSE:HIMS )

Whales with a lot of money to spend have taken a noticeably bearish stance on Hims & Hers Health. Looking at options history for Hims & Hers Health HIMS we detected 35 trades. If we consider the specifics of each trade, it is accurate to state that 40% of the investors opened trades with bullish ...

https://www.benzinga.com/insights/options/25/03/44465349/decoding-hims-hers-healths-options-activity-whats-the-big-picture

Trending Today

Discover Financial Services ($DFS) Stock Forecast: Up 5.0% Today

Robinhood Inc. ($HOOD) Stock Forecast: Up 5.0% Today

Rivian Automotive Inc. ($RIVN) Stock Forecast: Up 5.1% Today

Ford Motor Company ($F) Stock Forecast: Up 5.1% Today

Toncoin ($TON) Crypto Forecast: Up 7.2% Today

GameStop Corp. ($GME) Stock Forecast: Up 5.1% Today

Carvana Co ($CVNA) Stock Forecast: Up 7.1% Today

Applovin Corporation ($APP) Stock Forecast: Up 5.4% Today

Delta Air Lines Inc. ($DAL) Stock Forecast: Up 5.4% Today

Jupiter ($JUP) Crypto Forecast: Down 9.0% Today

Hims & Hers Health Inc. Price History

21.01.2025 - HIMS Stock was down 19.7%

• The recent acquisitions of a California-based peptide facility and an at-home lab testing facility by Hims & Hers Health could be linked to the bearish turn, possibly due to concerns around integration challenges and increased expenses.
• Market whales’ bearish positioning on HIMS options might have swayed investor sentiment, contributing to the stock's decline.
• Despite the company's efforts to expand its offerings, industry-wide macro challenges may have dampened the positive developments, driving the bearish sentiment.
• An undisclosed downgrade by a prominent Wall Street analyst could also have impacted investor confidence in Hims & Hers Health.

25.01.2025 - HIMS Stock was down 23.9%

• HIMS stock saw a significant bearish movement today.
• Despite exceeding fourth-quarter revenue expectations, an analyst maintained a Sell rating on HIMS stock.
• The company's Q4 earnings fell short of estimates, with both earnings and revenue below expectations.
• There was bullish activity in HIMS options by smart money, but the overall market sentiment stayed bearish, potentially reflecting concerns about the company's future performance following its recent earnings report.

25.01.2025 - HIMS Stock was down 8.7%

• The stock of HIMS experienced a strong bearish movement today.
• Despite surpassing analyst estimates in quarterly revenue, the company did not meet earnings expectations, leading to disappointment among investors.
• The acquisition of a California-based peptide facility and the resolution of the semaglutide shortage by the FDA were positive developments, but they were overshadowed by the earnings miss.
• Conflicting sentiments in options trading, with some financial giants taking a bullish stance while market whales bet bearishly, might have contributed to the stock's volatility and downward pressure.

25.01.2025 - HIMS Stock was down 22.4%

• Hims & Hers Health shares saw a significant decline following the Q4 results, despite revenue exceeding expectations, possibly leading to investor disappointment and a bearish trend.
• The drop in gross margin and failure to meet earnings estimates for the fourth quarter likely contributed to the negative stock performance of HIMS.
• Analysts issuing a Sell rating for the stock and decreasing price targets might have further pressured Hims & Hers Health shares downwards.
• In summary, the underperformance in revenue growth, declining gross margins, and analyst outlook could have all played a role in today's bearish movement in HIMS stock.

28.02.2025 - HIMS Stock was down 7.6%

• The stock of HIMS experienced a strong bearish movement recently.
• Smart money investors have taken a notably bearish stance on HIMS options, as a significant percentage have opened trades with bearish sentiments.
• The stock has been down 7.1% since the last earnings report, prompting concerns about its ability to rebound.
• The overall options activity for HIMS is leaning towards a bearish outlook, potentially contributing to the downward trend in the stock price.

13.02.2025 - HIMS Stock was down 5.5%

• Despite HIMS enhancing its offerings and expanding its product line in the health and wellness sector, macro challenges seem to be impacting its performance negatively.
• An increase in trades by major investors in HIMS might indicate short-term optimism. However, the overall market sentiment has overshadowed this positive sentiment, leading to a strong bearish movement in the stock today.
• Investors might be cautious due to macro challenges, causing them to sell off their positions in HIMS, contributing to the bearish movement observed today.

12.02.2025 - HIMS Stock was down 5.1%

• Despite bullish sentiment from whales and financial giants in the options market, HIMS stock experienced a bearish trend.
• Novo Nordisk's decision to lower the costs of Wegovy, a competitor in the health sector, may have impacted investor confidence in HIMS.
• The discounted price offered by Novo Nordisk could potentially attract customers away from HIMS, leading to a decrease in the stock price.
• The bearish movement in HIMS stock could be a result of increased competition and pricing pressures in the telehealth and wellness industry.

06.02.2025 - HIMS Stock was down 6.5%

• Despite surpassing revenue expectations and demonstrating robust subscriber growth, the stock witnessed a downward trend.
• Market sentiments possibly anticipated higher revenue figures or more substantial subscriber growth, prompting a sell-off.
• Concerns about the company's future growth trajectory or potential competition within the telehealth sector may have led to pessimism among investors towards the stock.
• Some investors may have opted to cash out and take profits following a period of solid performance, potentially contributing to the bearish movement.

06.02.2025 - HIMS Stock was down 11.0%

• Today's downward movement in HIMS stock may be due to profit-taking by investors following a prior period of bullish sentiment.
• Despite strong Q4 revenue and subscriber growth, the market's reaction could have been influenced by the company meeting, rather than surpassing, EPS expectations.
• Financial giants' optimistic positions in HIMS options likely initially boosted the stock, but subsequent profit-taking led to a sell-off.
• Investor focus shifting towards Novo Nordisk's reduced Wegovy costs and stock price rise may have negatively impacted HIMS performance.

26.02.2025 - HIMS Stock was down 5.6%

• The stock price of HIMS showed a strong bearish movement.
• Earnings were reported by the company 30 days ago, leading to investor uncertainty about a potential rebound.
• Options activity revealed a notable number of investors taking a bearish stance, suggesting a lack of confidence in the stock's short-term performance.
• The recent earnings report and bearish options activity likely played a role in the downward pressure on HIMS stock today.

25.02.2025 - HIMS Stock was up 5.7%

• Despite recent bearish options activity, Hims & Hers Health witnessed a strong bullish movement in the stock market today.
• The bullish momentum could be linked to positive earnings or key company developments fostering investor confidence.
• The bearish options activity may not have directly influenced today's stock performance, with market sentiment and other factors likely driving the upward trend.
• Positive reactions from investors to strategic partnerships, product innovations, or expansion plans might have spurred buying interest, pushing the stock price higher.

24.01.2025 - HIMS Stock was up 5.4%

• The recent acquisitions of a California-based peptide facility and an at-home lab testing facility have bolstered Hims & Hers Health's supply chain, enhanced quality control measures, and broadened its range of personalized healthcare services. This development likely instilled confidence in investors regarding the company's future growth potential.
• The resolution of the semaglutide shortage by regulatory authorities may have mitigated concerns related to supply chain disruptions for Hims & Hers Health, contributing to the upward movement in its stock price.
• While some significant market players have expressed bearish views on HIMS options, the overall market sentiment appears to be bullish, with many traders displaying optimism towards the company's future performance.
• The record-breaking stock prices and substantial surge over the past quarter indicate that the market is optimistic about HIMS' strategy of enhancing its offerings and expanding its portfolio of health and wellness products and services.